Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
spinal muscular atrophy
4
×
biogen
boston blog main
national
national blog main
national top stories
new york top stories
novartis
san francisco top stories
alexion pharmaceuticals
alzheimer's disease
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
drug prices
drug pricing
drugs
eli lilly
fda
gene therapy
genentech
indiana blog main
indiana top stories
investing
medicare
new york blog main
pain drug
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
What
drug
4
×
alzheimer’s
bio
biotech
investment
prices
roundup
annual
approved
assessed
atrophy
attention
communities
companies
conference
daily
different
driving
esmo
europe
evrysdi
fail
fda
friday
gene
germany
good
green
healthcare
history
home
hosted
improved
increases
industry
innovation
innovations
intended
latest
life
Language
unset
Current search:
drug
×
" spinal muscular atrophy "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
